Neutralizing Antibodies and CD8(+) T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors

The high prevalence of preexisting immunity to adenovirus serotype 5 (Ad5) in human populations will likely limit the immunogenicity and clinical utility of recombinant Ad5 vector-based vaccines for human immunodeficiency virus type 1 and other pathogens. Ad5-specific neutralizing antibodies (NAbs)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Virol
Main Authors: Sumida, Shawn M., Truitt, Diana M., Kishko, Michael G., Arthur, Janelle C., Jackson, Shawn S., Gorgone, Darci A., Lifton, Michelle A., Koudstaal, Wouter, Pau, Maria G., Kostense, Stefan, Havenga, Menzo J. E., Goudsmit, Jaap, Letvin, Norman L., Barouch, Dan H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2004
Assuntos:
Vaccines and Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC353774/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14990686/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.78.6.2666-2673.2004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados